Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Other Non-Current Assets: 2010-2025

Historic Other Non-Current Assets for BIO-TECHNE (TECH) over the last 16 years, with Jun 2025 value amounting to $283.9 million.

  • BIO-TECHNE's Other Non-Current Assets rose 0.31% to $276.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $276.6 million, marking a year-over-year increase of 0.31%. This contributed to the annual value of $283.9 million for FY2025, which is 7.44% up from last year.
  • BIO-TECHNE's Other Non-Current Assets amounted to $283.9 million in FY2025, which was up 7.44% from $264.3 million recorded in FY2024.
  • Over the past 5 years, BIO-TECHNE's Other Non-Current Assets peaked at $285.3 million during FY2023, and registered a low of $11.6 million during FY2021.
  • In the last 3 years, BIO-TECHNE's Other Non-Current Assets had a median value of $283.9 million in 2025 and averaged $277.8 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first fell by 14.40% in 2021, then skyrocketed by 509.26% in 2023.
  • Over the past 5 years, BIO-TECHNE's Other Non-Current Assets (Yearly) stood at $11.6 million in 2021, then spiked by 304.56% to $46.8 million in 2022, then soared by 509.26% to $285.3 million in 2023, then declined by 7.37% to $264.3 million in 2024, then climbed by 7.44% to $283.9 million in 2025.